IL190528A0 - Synergistic drug combinations for the treatment of ocular surface disorders - Google Patents

Synergistic drug combinations for the treatment of ocular surface disorders

Info

Publication number
IL190528A0
IL190528A0 IL190528A IL19052808A IL190528A0 IL 190528 A0 IL190528 A0 IL 190528A0 IL 190528 A IL190528 A IL 190528A IL 19052808 A IL19052808 A IL 19052808A IL 190528 A0 IL190528 A0 IL 190528A0
Authority
IL
Israel
Prior art keywords
treatment
ocular surface
drug combinations
synergistic drug
surface disorders
Prior art date
Application number
IL190528A
Original Assignee
Muhammad Abdulrazik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muhammad Abdulrazik filed Critical Muhammad Abdulrazik
Priority to IL190528A priority Critical patent/IL190528A0/en
Publication of IL190528A0 publication Critical patent/IL190528A0/en

Links

IL190528A 2008-03-31 2008-03-31 Synergistic drug combinations for the treatment of ocular surface disorders IL190528A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL190528A IL190528A0 (en) 2008-03-31 2008-03-31 Synergistic drug combinations for the treatment of ocular surface disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL190528A IL190528A0 (en) 2008-03-31 2008-03-31 Synergistic drug combinations for the treatment of ocular surface disorders

Publications (1)

Publication Number Publication Date
IL190528A0 true IL190528A0 (en) 2009-02-11

Family

ID=42104102

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190528A IL190528A0 (en) 2008-03-31 2008-03-31 Synergistic drug combinations for the treatment of ocular surface disorders

Country Status (1)

Country Link
IL (1) IL190528A0 (en)

Similar Documents

Publication Publication Date Title
EP2166837A4 (en) Drug combination for the treatment of skin disorders
HK1158172A1 (en) Compounds for treating ophthalmic diseases and disorders
GB201001047D0 (en) Methods and compositions for the treatment of neurological disorders
ZA200905962B (en) Combination therapy for treatment of immune disorders
EP2173344A4 (en) Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration
EP2278972A4 (en) Treatment for neurological and mental disorders
ZA201102640B (en) Use of scyllo-inositols for the treatment of macular degeneration-related disorders
IL208357A0 (en) Spiro-indole derivatives for the treatment of parasitic diseases
ZA201001262B (en) Interval therapy for the treatment of tinnitus
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
BRPI0917440A2 (en) ophthalmic pharmaceutical compositions for the treatment of neoangiogenic eye disorders
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
GB0915259D0 (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders
IL193799A0 (en) New therapeutic combinations for the treatment or prevention of psycotic disorders
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2328584A4 (en) Treatment of neurological disorders using huperzine
IL209417A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
IL207906A0 (en) Treatment for ocular-related disorders
SI2278962T1 (en) Methods for the treatment of dermatological disorders
SI2344166T1 (en) Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
EP2212246B1 (en) Treatment of neurological disorders
IL190528A0 (en) Synergistic drug combinations for the treatment of ocular surface disorders
GB0814043D0 (en) The treatment of skin disorders
IL219050A0 (en) Pharmaceutical composition for the treatment of bladder disorders